A study by an international research group identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset. The proteins…
Read More
Spinal fluid biomarkers detect neurodegeneration, Alzheimers disease in living patients
Alzheimer’s disease and related diseases can still only be confirmed in deceased patients’ brains via autopsy. Even so, the development of biomarkers can give patients and their families answers during life: Alzheimer’s disease can be accurately detected via peptides and…
Read More
Novel diabetes subgroups show differences in biomarkers of inflammation
Chronic inflammation is increasingly a focus of research. A recent study has now identified differences in indicators of inflammation between novel diabetes subgroups. But what does this mean for the future? Symptoms that increase with age, such as cardiovascular disease,…
Read More
Scientists identify new biomarkers in patients with malignant melanoma, which could help in its diagnosis and prognosis
A team of researchers has studied the molecular profile of small “messenger” vesicles called exosomes, produced by cancer stem cells (CSCs), which play a key role in the process of carcinogenesis and metastasis in the blood of patients with malignant…
Read More
Biomarkers could help predict severe SARS-CoV-2 infection
Molecular markers in the blood shown to be predictive of severe COVID-19 outcomes resulting from SARS-CoV-2 coronavirus infection have been identified in a study by a Chinese research team. The study results extend understanding of the pathophysiology and clinical progress…
Read More
Biomarkers may help us understand recovery time after concussion
A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020 online issue of Neurology, the medical journal of the American Academy of Neurology. The…
Read More